Systematic variation in gene expression patterns in human cancer cell lines
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
We used cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs. Classification of the cell lines based solely on the observed patterns of gene expression revealed a correspondence to the ostensible origins of the tumours from which the cell lines were derived. The consistent relationship between the gene expression patterns and the tissue of origin allowed us to recognize outliers whose previous classification appeared incorrect. Specific features of the gene expression patterns appeared to be related to physiological properties of the cell lines, such as their doubling time in culture, drug metabolism or the interferon response. Comparison of gene expression patterns in the cell lines to those observed in normal breast tissue or in breast tumour specimens revealed features of the expression patterns in the tumours that had recognizable counterparts in specific cell lines, reflecting the tumour, stromal and inflammatory components of the tumour tissue. These results provided a novel molecular characterization of this important group of human cell lines and their relationships to tumours in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results are consistent with studies performed previously, using STR profiling to examine authenticity, as well as expression profiling and mutation status to examine tissue origin.1, 2, 3, 32”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [1]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Self-citation(1975) · CERN Document Server (European Organization for Nuclear Research) · Cited by 5,958
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Self-citationAlon, U., Barkai, N., Notterman, D. A., Gish, K., Ybarra, S., Mack, D., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6745 · Cited by 4,167
Principles of Numerical Taxonomy
(2013) · Personality Structure and Measurement (Psychology Revivals) · doi:10.4324/9780203766804-11 · Cited by 2,990
Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E. S., & Golub, T. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2907 · Cited by 2,923
Exploring the new world of the genome with DNA microarrays
Brown, P. O., & Botstein, D. (1999) · Nature Genetics · doi:10.1038/4462 · Cited by 2,414
Self-citationThe Transcriptional Program in the Response of Human Fibroblasts to Serum
Iyer, V. R., Eisen, M. B., Ross, D. T., Schuler, G., Moore, T., Lee, J. C. F., Trent, J. M., Staudt, L. M., Hudson, J., Boguski, M. S., et al. (1999) · Science · doi:10.1126/science.283.5398.83 · Cited by 1,965
Self-citationDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A gene expression database for the molecular pharmacology of cancer
Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., et al. (2000) · Nature Genetics · doi:10.1038/73439 · Cited by 1,450
Self-citation
Research works printed but not linked: 1
- Moscow, J.A., Schneider, E., Ivy, S.P. & Cowan, K.H. Multidrug resistance. Cancer Chemother. Biol. Response Modif. 17, 139– 177 (1997).
Cited by
Items 101–183 of 183
Kerbel, R. S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.213 · Cited by 326
Tumor reversion: Correction of malignant behavior by microenvironmental cues
Kenny, P. A., & Bissell, M. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11491 · Cited by 326
NDR kinases regulate essential cell processes from yeast to humans
Hergovich, A., Stegert, M. R., Schmitz, D., & Hemmings, B. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1891 · Cited by 323
Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
Hollestelle, A., Elstrodt, F., Nagel, J. H. A., Kallemeijn, W. W., & Schutte, M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0263 · Cited by 320
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Moore, M. J., Wang, Q., Kennedy, C. J., & Silver, P. A. (2010) · Cell · doi:10.1016/j.cell.2010.07.019 · Cited by 316
Epithelial mesenchymal transition traits in human breast cancer cell lines
Blick, T., Widodo, E., Hugo, H., Waltham, M., Lenburg, M. E., Neve, R. M., & Thompson, E. W. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9170-6 · Cited by 314
Self-citationCelis, J. E., Kruhøffer, M., Gromova, I., Frederiksen, C., Østergaard, M., Thykjaer, T., Gromov, P., Yu, J., Pálsdóttir, H., Magnusson, N., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01771-3 · Cited by 314
Waring, J. F., Ciurlionis, R., Jolly, R. A., Heindel, M., & Ulrich, R. G. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00267-3 · Cited by 313
Sun, Q., Zhou, W.-X., & Fan, J. (2020) · Journal of the American Statistical Association · doi:10.1080/01621459.2018.1543124 · Cited by 312
ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs
Balwierz, P. J., Pachkov, M., Arnold, P., Gruber, A. J., Zavolan, M., & van Nimwegen, E. (2014) · Genome Research · doi:10.1101/gr.169508.113 · Cited by 309
Pontén, F., Schwenk, J. M., Asplund, A., & Edqvist, P.-H. D. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02427.x · Cited by 305
Gene selection with guided regularized random forest
Deng, H., & Runger, G. (2013) · Pattern Recognition · doi:10.1016/j.patcog.2013.05.018 · Cited by 304
A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
Aoki, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011528498 · Cited by 303
LIFE ISN'T FLAT: TAKING CANCER BIOLOGY TO THE NEXT DIMENSION
SMALLEY, K. S. M., LIONI, M., & HERLYN, M. (2006) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0604027.1 · Cited by 302
Caveolin-1 in tumor progression: the good, the bad and the ugly
Goetz, J. G., Lajoie, P., Wiseman, S. M., & Nabi, I. R. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9160-9 · Cited by 299
Expression profiling of epithelial plasticity in tumor progression
Jechlinger, M., Grunert, S., Tamir, I. H., Janda, E., Lüdemann, S., Waerner, T., Seither, P., Weith, A., Beug, H., & Kraut, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206887 · Cited by 294
Hybrid Volatolomics and Disease Detection
Broza, Y. Y., Mochalski, P., Ruzsanyi, V., Amann, A., & Haick, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500153 · Cited by 290
Membrane Transporters and Channels
Huang, Y., Anderle, P., Bussey, K. J., Barbacioru, C., Shankavaram, U., Dai, Z., Reinhold, W. C., Papp, A., Weinstein, J. N., & Sadée, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3884 · Cited by 285
Self-citationSparse canonical methods for biological data integration: application to a cross-platform study
Lê Cao, K.-A., Martin, P. G., Robert-Granié, C., & Besse, P. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-34 · Cited by 283
Microarray results: how accurate are they?
Kothapalli, R., Yoder, S. J., Mane, S., & Loughran, T. P. (2002) · BMC Bioinformatics · doi:10.1186/1471-2105-3-22 · Cited by 282
Towards a novel classification of human malignancies based on gene expression patterns
Alizadeh, A. A., Ross, D. T., Perou, C. M., & van de Rijn, M. (2001) · The Journal of Pathology · doi:10.1002/path.889 · Cited by 280
Self-citationTumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
Goodspeed, A., Heiser, L. M., Gray, J. W., & Costello, J. C. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0189 · Cited by 276
Cancer transcriptome profiling at the juncture of clinical translation
Cieślik, M., & Chinnaiyan, A. M. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.96 · Cited by 269
PALINSKI, W., & NAPOLI, C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0226rev · Cited by 268
Display technologies: Application for the discovery of drug and gene delivery agents☆
SERGEEVA, A., KOLONIN, M., MOLLDREM, J., PASQUALINI, R., & ARAP, W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.018 · Cited by 266
van der Pouw Kraan, T. C. T. M., van Gaalen, F. A., Kasperkovitz, P. V., Verbeet, N. L., Smeets, T. J. M., Kraan, M. C., Fero, M., Tak, P., Huizinga, T. W. J., Pieterman, E., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11096 · Cited by 265
Han, S. H., Jeon, J. H., Ju, H. R., Jung, U., Kim, K. Y., Yoo, H. S., Lee, Y. H., Song, K. S., Hwang, H. M., Na, Y. S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206610 · Cited by 264
Molecular portraits and the family tree of cancer
Chung, C. H., Bernard, P. S., & Perou, C. M. (2002) · Nature Genetics · doi:10.1038/ng1038 · Cited by 262
Self-citationGene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA Microarray
Higgins, J. P. T., Shinghal, R., Gill, H., Reese, J. H., Terris, M., Cohen, R. J., Fero, M., Pollack, J. R., van de Rijn, M., & Brooks, J. D. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63887-4 · Cited by 260
Self-citationGenetic algorithms applied to multi-class prediction for the analysis of gene expression data
Ooi, C. H., & Tan, P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.1.37 · Cited by 257
MSVM-RFE: extensions of SVM-RFE for multiclass gene selection on DNA microarray data
Zhou, X., & Tuck, D. P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm036 · Cited by 256
Targeted anticancer therapy: Overexpressed receptors and nanotechnology
Akhtar, M. J., Ahamed, M., Alhadlaq, H. A., Alrokayan, S. A., & Kumar, S. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.05.004 · Cited by 255
Amundson, S. A., Do, K. T., Vinikoor, L. C., Lee, R. A., Koch-Paiz, C. A., Ahn, J., Reimers, M., Chen, Y., Scudiero, D. A., Weinstein, J. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2120 · Cited by 253
Self-citationToxicogenomics-Based Discrimination of Toxic Mechanism in HepG2 Human Hepatoma Cells
Burczynski, M. E. (2000) · Toxicological Sciences · doi:10.1093/toxsci/58.2.399 · Cited by 253
Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J. (2005) · Neoplasia · doi:10.1593/neo.04430 · Cited by 251
MicroRNA expression profiles for the NCI-60 cancer cell panel
Blower, P. E., Verducci, J. S., Lin, S., Zhou, J., Chung, J.-H., Dai, Z., Liu, C.-G., Reinhold, W., Lorenzi, P. L., Kaldjian, E. P., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0009 · Cited by 248
“with those used for the study to be described here have included the following: transcript profiling on multiple platforms (2, 3, 7, 14, 15); proteomic profiling using twodimensional gels (16) and lysate arrays (15, 17, 18); analysis of single nucleotide polymorphism (19); DNA resequencing for mutational status (20);…”
BackgroundMethodInfluentialSelf-citationHiggins, J. P. T., Kaygusuz, G., Wang, L., Montgomery, K., Mason, V., Zhu, S. X., Marinelli, R. J., Presti, J. C., van de Rijn, M., & Brooks, J. D. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213438.01278.5f · Cited by 237
Self-citationGene expression profiling of cutaneous wound healing
Deonarine, K., Panelli, M. C., Stashower, M. E., Jin, P., Smith, K., Slade, H. B., Norwood, C., Wang, E., Marincola, F. M., & Stroncek, D. F. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-11 · Cited by 229
MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Chambers, A. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1528 · Cited by 218
“In addition to the expression array study by Ross and colleagues (6), Sellappan and colleagues have reported that these cells express melanocyte”
BackgroundInfluentialSupervised harvesting of expression trees
Hastie, T., Tibshirani, R., Botstein, D., & Brown, P. (2001) · Genome Biology · doi:10.1186/gb-2001-2-1-research0003 · Cited by 216
Self-citationMammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin
Manuel Iglesias, J., Beloqui, I., Garcia-Garcia, F., Leis, O., Vazquez-Martin, A., Eguiara, A., Cufi, S., Pavon, A., Menendez, J. A., Dopazo, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077281 · Cited by 212
“Due to the conflicting results reported in the literature [32], MDA-MB-435 expression profile was not included in the analysis neither.”
ResultSystematic discovery of structural elements governing stability of mammalian messenger RNAs
Goodarzi, H., Najafabadi, H. S., Oikonomou, P., Greco, T. M., Fish, L., Salavati, R., Cristea, I. M., & Tavazoie, S. (2012) · Nature · doi:10.1038/nature11013 · Cited by 187
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
Wang, X., Osada, T., Wang, Y., Yu, L., Sakakura, K., Katayama, A., McCarthy, J. B., Brufsky, A., Chivukula, M., Khoury, T., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq343 · Cited by 188
Multiclass cancer classification and biomarker discovery using GA-based algorithms
Liu, J. J., Cutler, G., Li, W., Pan, Z., Peng, S., Hoey, T., Chen, L., & Ling, X. B. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti419 · Cited by 185
“Microarraybased tumor comparative hybridization profiles have been introduced for binary and multiclass cancer classifications (Ross et al., 2000; Ramaswamy et al., 2001; Su et al., 2001; Yeang et al., 2001; Ooi and Tan, 2003; Peng et al., 2003).”
BackgroundClarke, P. A., te Poele, R., Wooster, R., & Workman, P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00785-7 · Cited by 184
Kim, J.-M., Sohn, H.-Y., Yoon, S. Y., Oh, J.-H., Yang, J. O., Kim, J. H., Song, K. S., Rho, S.-M., Yoo, H. S., Kim, Y. S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.473.11.2 · Cited by 182
Crnogorac‐Jurcevic, T., Missiaglia, E., Blaveri, E., Gangeswaran, R., Jones, M., Terris, B., Costello, E., Neoptolemos, J. P., & Lemoine, N. R. (2003) · The Journal of Pathology · doi:10.1002/path.1418 · Cited by 180
HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
Stronach, E. A., Alfraidi, A., Rama, N., Datler, C., Studd, J. B., Agarwal, R., Guney, T. G., Gourley, C., Hennessy, B. T., Mills, G. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4111 · Cited by 176
“Cisplatin response was measured by sulforhodamine B (SRB) assay as described (8).”
Xu, Q. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg786 · Cited by 176
“One of the most prevalent and successful models in cancer research is that cancer involves changes in gene expression (1).”
BackgroundAdvances in the preclinical testing of cancer therapeutic hypotheses
Caponigro, G., & Sellers, W. R. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3385 · Cited by 165
DNA fingerprinting of the NCI-60 cell line panel
Lorenzi, P. L., Reinhold, W. C., Varma, S., Hutchinson, A. A., Pommier, Y., Chanock, S. J., & Weinstein, J. N. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0921 · Cited by 166
“However, we found on the basis of transcript expression profiles and other characteristics that they are melanomas (21, 22).”
BackgroundSelf-citationMolecular determinants of human uveal melanoma invasion and metastasis
Seftor, E. A., Meltzer, P. S., Kirschmann, D. A., Pe'er, J., Maniotis, A. J., Trent, J. M., Folberg, R., & Hendrix, M. J. C. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015591624171 · Cited by 165
“Microarray analysis technology has yielded a number of reports that have attempted to classify a variety of tumors based on the differential expression of known (and unknown) genes [27–30].”
BackgroundFurther evidence to support the melanocytic origin of MDA-MB-435
Ellison, G. (2002) · Molecular Pathology · doi:10.1136/mp.55.5.294 · Cited by 164
“…cell line in the National Cancer Institute (NCI60) collection showed more resemblance to melanoma derived cell lines than would have been expected, 3 although because other breast cancer derived cells failed to give a simple clustering pattern (as seen for renal cancer and leukaemia) a…”
BackgroundLineage Infidelity of MDA-MB-435 Cells
Sellappan, S., Grijalva, R., Zhou, X., Yang, W., Eli, M. B., Mills, G. B., & Yu, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3299-2 · Cited by 163
“In our study, the MDA-MB-435 cell line expressed the specific melanocyte proteins tyrosinase and melan-A; this is consistent with previous reports that found similar gene expression patterns in melanoma cell lines and the MDA-MB-435 cell line, but not in other breast cancer cell lines (5, 6).”
BackgroundResultIn Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
Niu, N., & Wang, L. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.170 · Cited by 162
Sachdev, D., Hartell, J. S., Lee, A. V., Zhang, X., & Yee, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305403200 · Cited by 160
Tekle, C., Nygren, M. K., Chen, Y., Dybsjord, I., Nesland, J. M., Mælandsmo, G. M., & Fodstad, Ø. (2012) · International Journal of Cancer · doi:10.1002/ijc.26238 · Cited by 159
Liscovitch, M., & Ravid, D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.01.013 · Cited by 152
Persistent use of “false” cell lines
Lacroix, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23233 · Cited by 151
“found to cluster with melanoma cells, rather than with other breast cancer cell lines.(38) Afterward, MDA-MB-435 cells were found to”
ResultProteasome activation by small molecules
Leestemaker, Y., de Jong, A., Witting, K. F., Penning, R., Schuurman, K., Rodenko, B., Zaal, E. A., van de Kooij, B., Laufer, S., Heck, A. J. R., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.05.010 · Cited by 144
Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
Panelli, M. C., White, R., Foster, M., Martin, B., Wang, E., Smith, K., & Marincola, F. M. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-17 · Cited by 139
“Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines.”
MethodJansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132
“Table 2 provides a comparison of Pdcd4 protein levels to the published PDCD4 gene expression levels determined by microarray analysis of the NCI60 cells (25, 26).”
ResultZschenker, O., Streichert, T., Hehlgans, S., & Cordes, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034279 · Cited by 129
“For example, both A549 and UT-SCC15 showed distinctive basal patterns of genes encoding for proteins with functions in the modulation of the ECM like Laminin, Fibronectin, Collagen, a finding similarly observed in a basal gene expression analysis of 60 cancer cell lines and their corresponding cancer tissues and in a…”
Backgroundvan Staveren, W. C. G., Solís, D. W., Delys, L., Duprez, L., Andry, G., Franc, B., Thomas, G., Libert, F., Dumont, J. E., Detours, V., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4026 · Cited by 123
“Solid tumors have a complex histologic organization with transformed thyrocytes, endothelial cells, fibroblasts, blood cells, and sometimes with lymphocyte infiltrates, all interacting with each other (28).”
BackgroundTwo CD95 tumor classes with different sensitivities to antitumor drugs
Algeciras-Schimnich, A., Pietras, E. M., Barnhart, B. C., Legembre, P., Vijayan, S., Holbeck, S. L., & Peter, M. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034995100 · Cited by 118
Using the reconstructed genome-scale human metabolic network to study physiology and pathology
Bordbar, A., & Palsson, B. O. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02494.x · Cited by 115
Duncan, R. E., El-Sohemy, A., & Archer, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400732200 · Cited by 113
The role of kindlins in cell biology and relevance to human disease
Lai-Cheong, J. E., Parsons, M., & McGrath, J. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.015 · Cited by 92
The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles
Sandberg, R., & Ernberg, I. (2005) · Genome Biology · doi:10.1186/gb-2005-6-8-r65 · Cited by 84
“Cell lines from colon [9], breast [10], lymphoma [11], leukemia [2], and lung origin [12] have been compared to their corresponding in vivo malignancies.”
BackgroundResultInfluentialLenferink, A. E. G., Cantin, C., Nantel, A., Wang, E., Durocher, Y., Banville, M., Paul-Roc, B., Marcil, A., Wilson, M. R., & O'Connor-McCourt, M. D. (2010) · Oncogene · doi:10.1038/onc.2009.399 · Cited by 81
“…EMT data sets from TGF-b1-treated NMuMG mouse mammary epithelial cells (Xie et al., 2003; Valcourt et al., 2005), whereas 16 of our upregulated transcripts can also be found in a subset of human NCI-60 cancer cell lines displaying a mesenchymal phenotype (Ross et al., 2000) (Supplementary Table 2).”
BackgroundMapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode
Agrawal, P., Kurcon, T., Pilobello, K. T., Rakus, J. F., Koppolu, S., Liu, Z., Batista, B. S., Eng, W. S., Hsu, K.-L., Liang, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321524111 · Cited by 77
Common origins of MDA-MB-435 cells from various sources with those shown to have melonoma properties
Rae, J. M., Ramus, S. J., Waltham, M., Armes, J. E., Campbell, I. G., Clarke, R., Barndt, R. J., Johnson, M. D., & Thompson, E. W. (2004) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-3759-1 · Cited by 74
“We obtained DNA from the MDA-MB-435-DTP cells arrayed by Ross et al. (2000) [6] to compare it with DNA from the same cell line which was obtained from the same original source (MDA-MB-435-LCC) and used in our institutions.”
Self-citationHLA class I and II genotype of the NCI-60 cell lines
Adams, S., Robbins, F.-M., Chen, D., Wagage, D., Holbeck, S. L., Morse, H. C., Stroncek, D., & Marincola, F. M. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-11 · Cited by 68
Zheng, X., Resnick, R. J., & Shalloway, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23321 · Cited by 60
“(We note that expression array analysis of MDA-MB-435, the parent cell line of MDA-MB-435S, suggests that this cell line may have been established from an occult melanoma, rather than a metastatic breast adenocarcinoma.(34) This possibility has been considered in interpreting the results.”
Korch, C., Hall, E. M., Dirks, W. G., Ewing, M., Faries, M., Varella‐Garcia, M., Robinson, S., Storts, D., Turner, J. A., Wang, Y., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31067 · Cited by 54
“Questions were first raised regarding the tissue origin of MDA-MB-435 in 2000, when cDNA microarray analysis of the NCI-60 panel showed that the expression pattern of the claimed breast carcinoma cells closely resembled patterns seen in melanoma cell lines.(1) Similar results were reported by other laboratories.”
ResultZhang, Q., Fan, H., Shen, J., Hoffman, R. M., & Xing, H. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009712 · Cited by 53
“Based on the close clustering of MDA-MB-435 cells with melanoma cell lines in microarray analysis [5], the possibility of the breast cancer patient, from whom MDA-MB-435 was derived from, having an undetected occult melanoma was suggested.”
Anderson, K. (2003) · Brain · doi:10.1093/brain/awg208 · Cited by 51
“Microarrays were designed to try to uncover pathways that are differentially regulated between different DNA populations, and notable advances have been made within oncogene pathways and with the understanding of cell cycle control (Primig et al., 2000; Ross et al., 2000).”
BackgroundCorrelation signature of the macroscopic states of the gene regulatory network in cancer
Slavov, N., & Dawson, K. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810803106 · Cited by 49
Expression of melanocyte-related genes in human breast cancer and its implications
Montel, V., Suzuki, M., Galloy, C., Mose, E. S., & Tarin, D. (2009) · Differentiation · doi:10.1016/j.diff.2009.07.007 · Cited by 35
“The multiple converging lines of reproducible evidence that we have described support the conclusion that the MDA-MB-435 cell line is of breast origin and indicate that the recent claims (Ross et al., 2000; Jessani et al., 2002; Ellison et al., 2002; Rae et al., 2007) that it is of melanocytic origin are incorrect.”
BackgroundResultCharacterization and authentication of cancer cell lines: an overview
Reid, Y. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-080-5_4 · Cited by 34
Density-dependent lineage instability of MDA-MB-435 breast cancer cells
NERLICH, A. G., & BACHMEIER, B. E. (2013) · Oncology Letters · doi:10.3892/ol.2013.1157 · Cited by 23
Huh, Y. H., Noh, M., Burden, F. R., Chen, J. C., Winkler, D. A., & Sherley, J. L. (2015) · Stem Cell Research · doi:10.1016/j.scr.2014.12.007 · Cited by 20
Multidimensional profiling in the investigation of small-molecule-induced cell death
Wolpaw, A. J., & Stockwell, B. R. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801430-1.00011-1 · Cited by 10
“Further studies have integrated genome-wide expression data (Ross et al., 2000; Scherf et al., 2000), proteomic profiles (Nishizuka et al., 2003; Park et al., 2010; Shankavaram et al., 2007), and mutation data (Ikediobi et al., 2006).”
Background
Metadata
- Authors
- Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J. C. F., Lashkari, D., Shalon, D., Myers, T. G., Weinstein, J. N., Botstein, D., & Brown, P. O.
- Affiliations
- Stanford Medicine (US)
- National Institutes of Health (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Weinstein, John N.
- Brown, Patrick O.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-03
- Volume
- 24
- Issue
- 3
- Pages
- 227-235
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1989076816
- Cited by
- 2,088
- References
- 44
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 8 · 2023: 37 · 2022: 24 · 2021: 34 · 2020: 24 · 2019: 42 · 2018: 49 · 2017: 50 · 2016: 41 · 2015: 55 · 2014: 63 · 2013: 73 · 2012: 76
- FWCI
- 58.88
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Alfred P. Sloan Foundation
- Life Sciences Research Foundation
- National Cancer Institute (CA 077097, R01CA077097)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- gene expression patterns, human cancer cell lines, NCI-60, cell line classification, cell doubling time, drug metabolism, interferon response, breast cancer, tumor stroma, tumor inflammation
- MeSH terms
- Breast, Breast Neoplasms, Female, Humans, Leukemia, Neoplasm Proteins, Neoplasms, Organ Specificity, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Cluster Analysis, DNA, Complementary, Expressed Sequence Tags, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.